About BioPorto Diagnostics

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Their pioneering product portfolio includes assays for underserved disease states, such as NGAL for acute kidney injury. They sell their products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exc

Company Highlights
Year Founded

1995

icon-altEmployees

46

Location (HQ)

DNK

Since Last Funding

1 year 1 month

Monthly Website Visitors

11.2K

icon-altTotal Investment Amt

$100K

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

-13.18%

icon-altYoY Headcount Growth

9.5%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Diagnostics